SCHEMBL4336462

SCHEMBL4336462

CCOC(C(N)=O)n1nc(-c2cccc(F)c2)c2cc(C(=O)O)c(C)cc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK1D P48730 1/20 0.38
JAK2 O60674 1/20 0.38
JAK3 P52333 1/20 0.38
MAPT P10636 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
KDM4E B2RXH2 1/20 0.38
PTGER1 P34995 1/20 0.36
DCLRE1B Q9H816 1/20 0.35
TRPM8 Q7Z2W7 1/20 0.35
CFTR P13569 1/20 0.35
TACR3 P29371 2/20 0.34
PTGFR P43088 1/20 0.34
DHODH Q02127 3/20 0.34
ELANE P08246 1/20 0.34
GPR35 Q9HC97 1/20 0.33
MEN1 O00255 1/20 0.33
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33
KMT2A Q03164 1/20 0.33
ICMT O60725 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4339201 0.83 JAK2 (0.38) CSNK1DJAK2JAK3KDM4EPTGER1
SCHEMBL4336324 0.82 PTGER1 (0.38) CSNK1DJAK2KDM4EPTGER1DCLRE1B
SCHEMBL4348125 0.79 PTGER1 (0.41) CSNK1DKDM4EPTGER1PTGFRDHODH
SCHEMBL4328987 0.77 CTSA (0.41) PTGER1
SCHEMBL4342241 0.75 CSNK1E (0.34) CSNK1DMAPTL3MBTL1KDM4EPTGER1
SCHEMBL4343207 0.74 PTGER1 (0.38) CSNK1DKDM4EPTGER1DCLRE1BTACR3
SCHEMBL4332632 0.73 PTPN11 (0.41) CSNK1DKDM4EPTGER1DCLRE1BGPR35
SCHEMBL4334488 0.72 PTGER1 (0.37) CSNK1DMAPTKDM4EPTGER1TACR3
SCHEMBL4334606 0.72 PTPN11 (0.41) CSNK1DKDM4EPTGER1TACR3
SCHEMBL4340976 0.71 MAPT (0.38) CSNK1DMAPTKDM4EPTGER1TACR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 CSNK1D 134/4885JAK2 145/4885JAK3 776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.